BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14619464)

  • 1. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
    Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
    Kawaoka T; Yoshino S; Kondo H; Yamamoto K; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
    Yoshino S; Yoshida S; Maeda N; Maeda Y; Maeda K; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2798-800. PubMed ID: 21224717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
    Ishimori S; Okada S; Yamagata S; Satoh S
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
    Kang MQ; Cao YP; Deng F
    Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunochemotherapy of carcinomatous peritonitis and pleuritis--report of 2 cases].
    Takekoshi H; Yoshida K; Morinaga S
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1466-9. PubMed ID: 1326910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
    Kan N
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
    Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
    Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Ohsumi K; Kudo N; Mukaihara S
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1632-5. PubMed ID: 1530322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
    Kan N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapleural chemo- and hyperthermotherapies for malignant pleural effusion: a randomized prospective study.
    Chen WJ; Yuan SF; Yan QY; Xiong JP; Wang SM; Zheng WE; Zhang W; Sun HY; Chen H; Wu LL
    Cancer Invest; 2012 Feb; 30(2):126-30. PubMed ID: 22148972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
    Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
    Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
    Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
    Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
    Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
    Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
    Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
    SHI Z; HE QY; HUA BJ
    Chin J Integr Med; 2008 Dec; 14(4):257-61. PubMed ID: 19082796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on the Th1/Th2 cytokines in the pathogenesis of human tuberculous pleuritis].
    Li YH; Xie CM
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 May; 27(5):324-7. PubMed ID: 15196342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.